Rocket


News + Filings
Transactions



Edwards Martin

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
09/26/2023REATA PHARMACEUTICALS INCRETADispositionClass A common stock6.1k$0.00$0 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)10k$149.29$1.5M 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)6.3k$149.29$940.5k 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)5k$146.01$730k 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)99$27.32$2.7k 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)520$34.76$18.1k 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)5.6k$34.76$195.4k 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)169$93.61$15.8k 09/26/2023
09/26/2023REATA PHARMACEUTICALS INCRETADispositionStock Option (right to buy)2.1k$93.61$200k 09/26/2023
06/07/2023REATA PHARMACEUTICALS INCRETAGrantClass A common stock1.7k$93.61$157.5k 06/07/2023
06/07/2023REATA PHARMACEUTICALS INCRETAGrantStock Option (right-to-buy)169$93.61$15.8k 06/07/2023
06/07/2023REATA PHARMACEUTICALS INCRETAGrantStock Option (right-to-buy)2.1k$93.61$200k 06/07/2023
06/07/2023REATA PHARMACEUTICALS INCRETAGrantClass A common stock133$93.61$12.5k 06/07/2023
06/01/2023Morphic Holding, Inc.MORFGrantDirector Stock Option (Right to Buy)12.5k$56.47$707.9k 06/01/2023
04/28/2023Verona Pharma plcVRNAGrantShare Options (Right to Buy)96k$0.00$0 04/28/2023
06/10/2022Inozyme Pharma, Inc.INZYGrantStock Option (right to buy)9.4k$4.38$41k 06/10/2022
06/08/2022REATA PHARMACEUTICALS INCRETAGrantClass A common stock359$34.76$12.5k 06/08/2022
06/08/2022REATA PHARMACEUTICALS INCRETAGrantClass A common stock3.9k$34.76$135k 06/08/2022
06/08/2022REATA PHARMACEUTICALS INCRETAGrantStock Option (right-to-buy)520$34.76$18.1k 06/08/2022
06/08/2022REATA PHARMACEUTICALS INCRETAGrantStock Option (right-to-buy)5.6k$34.76$195.4k 06/08/2022
06/08/2022Morphic Holding, Inc.MORFGrantDirector Stock Option (Right to Buy)17.6k$24.49$429.8k 06/08/2022
01/03/2022REATA PHARMACEUTICALS INCRETAGrantStock Option (right to buy)99$27.32$2.7k 01/03/2022
01/03/2022REATA PHARMACEUTICALS INCRETAGrantClass A common stock59$27.32$1.6k 01/03/2022
09/30/2021KalVista Pharmaceuticals, Inc.KALVGrantDirector Stock Option (Right to Buy)10k$17.45$174.5k 09/30/2021
08/09/2021Verona Pharma plcVRNAGrantShare Options (Right to Buy)64k$0.00$0 08/09/2021
06/23/2021Inozyme Pharma, Inc.INZYGrantStock Option (right to buy)9.4k$17.12$160.4k 06/23/2021
06/16/2021Morphic Holding, Inc.MORFGrantDirector Stock Option (right to buy)12k$64.79$777.5k 06/16/2021
06/16/2021Morphic Holding, Inc.MORFGrantDirector Stock Option (right to buy)10k$64.79$647.6k 06/16/2021
06/10/2021REATA PHARMACEUTICALS INCRETAGrantStock Option (right to buy)5k$146.01$730k 06/10/2021
05/04/2021Verona Pharma plcVRNASale 12k$0.84$10.1k 05/04/2021
02/01/2021Verona Pharma plcVRNASale 13.7k$0.99$13.6k 02/01/2021
12/01/2020Morphic Holding, Inc.MORFGrantStock Option (right to buy Common Stock)24k$31.00$744k 12/01/2020
10/01/2020KalVista Pharmaceuticals, Inc.KALVGrantDirector Stock Option (right to buy)7k$12.88$90.2k 10/01/2020
08/03/2020REATA PHARMACEUTICALS INCRETAGrantStock Option (right to buy)10k$149.29$1.5M 08/03/2020
08/03/2020REATA PHARMACEUTICALS INCRETAGrantStock Option (right to buy)6.3k$149.29$940.5k 08/03/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy